Depot medroxyprogesterone acetate and endometrial cancer: A multicenter case-control study.

Chumnan KietpeerakoolChalong CheewakriangkraiSiwanon RattanakanokchaiDaungporn RattanalappaiboonJitima TiyayonWadwilai ChalapatiThumwadee TangsiriwattanaSiriwan TangjitgamolPilaiwan KleebkaowSurapan KhunamornpongAmornrat TemtanakitpaisanNarisa SribanditmongkholPisake Lumbiganon

Published in: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (2023)

Depot medroxyprogesterone acetate use was inversely associated with endometrial cancer risk in a duration-dependent manner. This association was independent of cancer subtype.

Keyphrases

endometrial cancer
papillary thyroid
squamous cell
cross sectional
double blind
young adults
childhood cancer